Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome)

Overview


Plain-Language Overview

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome) is a serious condition that affects the brain and nervous system. It happens when the body does not get enough thiamine, a vitamin important for turning food into energy and maintaining healthy nerve function. This deficiency can cause problems with memory, coordination, and eye movements. People with this condition may experience confusion, difficulty walking, and abnormal eye movements. If untreated, it can lead to permanent brain damage and severe memory loss. The syndrome often occurs in people with chronic alcohol use disorder or malnutrition. Early recognition is important to prevent lasting harm.

Clinical Definition

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome) is a neuropsychiatric disorder caused by a deficiency of thiamine, an essential cofactor for enzymes in cerebral energy metabolism. The syndrome comprises two overlapping clinical entities: Wernicke encephalopathy, characterized by acute neurological symptoms including ophthalmoplegia, ataxia, and confusion, and Korsakoff syndrome, a chronic condition marked by severe anterograde amnesia and confabulation. The deficiency impairs the function of thiamine-dependent enzymes such as transketolase, leading to neuronal injury primarily in the mammillary bodies, thalamus, and brainstem. It is most commonly caused by chronic alcoholism, malnutrition, or malabsorption states. The condition is a medical emergency due to the risk of irreversible brain damage and death if untreated.

Inciting Event

  • Prolonged dietary thiamine deficiency due to poor intake or absorption initiates the syndrome.

  • Acute illness or infection can increase metabolic demand and precipitate symptoms.

  • Alcohol withdrawal or cessation may unmask underlying deficiency by increasing metabolic needs.

  • Administration of glucose without thiamine supplementation can precipitate acute Wernicke encephalopathy.

Latency Period

  • Symptoms typically develop within weeks to months of sustained thiamine deficiency.

  • Acute Wernicke encephalopathy can appear rapidly after a precipitating event such as glucose administration.

  • Korsakoff syndrome develops as a chronic sequela weeks to months after untreated Wernicke encephalopathy.

Diagnostic Delay

  • Nonspecific early symptoms such as confusion and ataxia are often misattributed to intoxication or other neurological disorders.

  • Lack of awareness of nutritional deficiency in non-alcoholic patients delays diagnosis.

  • Failure to recognize the classic triad of ophthalmoplegia, ataxia, and confusion leads to missed diagnosis.

  • Inadequate thiamine testing and reliance on clinical diagnosis can delay treatment.

Clinical Presentation


Signs & Symptoms

  • Confusion, disorientation, and memory impairment characteristic of Wernicke encephalopathy

  • Ophthalmoplegia including lateral rectus palsy causing diplopia

  • Ataxia affecting gait and stance

  • Anterograde and retrograde amnesia with confabulation in Korsakoff syndrome

  • Peripheral neuropathy with burning sensations and weakness

History of Present Illness

  • Initial presentation often includes acute confusion and disorientation progressing over days.

  • Ophthalmoplegia or nystagmus develops early due to cranial nerve involvement.

  • Gait ataxia and unsteady stance appear as cerebellar and vestibular dysfunction worsen.

  • If untreated, memory impairment and confabulation emerge, indicating progression to Korsakoff syndrome.

Past Medical History

  • History of chronic alcohol use disorder is common and increases suspicion.

  • Previous episodes of malnutrition or gastrointestinal surgery may be present.

  • Conditions causing malabsorption such as celiac disease or inflammatory bowel disease are relevant.

  • Prior episodes of hyperemesis gravidarum or prolonged vomiting may be noted.

Family History

  • []

Physical Exam Findings

  • Nystagmus and ophthalmoplegia due to cranial nerve VI and III involvement

  • Ataxic gait and broad-based stance reflecting cerebellar dysfunction

  • Confusion and impaired consciousness indicating acute encephalopathy

  • Peripheral neuropathy with decreased sensation and diminished reflexes

  • Hypotension and tachycardia in severe cases due to autonomic dysfunction

Diagnostic Workup


Diagnostic Criteria

Diagnosis is clinical, based on the presence of the classic triad of ophthalmoplegia, ataxia, and confusion in a patient with risk factors such as alcoholism or malnutrition. Brain MRI may show characteristic hyperintensities in the mammillary bodies and medial thalami. Measurement of erythrocyte transketolase activity or thiamine levels can support the diagnosis but are not routinely required. A positive response to thiamine administration can also aid diagnosis. Early recognition and treatment are critical to prevent progression to Korsakoff syndrome.

Pathophysiology


Key Mechanisms

  • Thiamine (vitamin B1) deficiency impairs activity of thiamine-dependent enzymes including pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase, leading to decreased ATP production and neuronal energy failure.

  • Accumulation of lactate and glutamate causes neuronal damage and excitotoxicity in vulnerable brain regions.

  • Selective vulnerability of the mammillary bodies, medial thalami, periaqueductal gray matter, and cerebellar vermis results in characteristic neurological deficits.

  • Disruption of neurotransmitter synthesis and myelin maintenance contributes to cognitive and motor symptoms.

InvolvementDetails
Organs

Brain is the primary organ affected, with damage to regions involved in memory and coordination causing the clinical triad of ophthalmoplegia, ataxia, and confusion.

Gastrointestinal tract involvement may contribute to malabsorption and worsened nutritional deficiency.

Tissues

Brain tissue, especially the mammillary bodies and periventricular regions, shows characteristic lesions in Wernicke-Korsakoff syndrome.

Cells

Neurons are primarily affected due to impaired energy metabolism from thiamine deficiency leading to neurodegeneration.

Astrocytes contribute to maintaining neuronal health and are involved in the metabolic disturbances seen in this syndrome.

Chemical Mediators

Thiamine pyrophosphate is the active coenzyme form of thiamine essential for mitochondrial enzymes like pyruvate dehydrogenase.

Lactate accumulation occurs due to impaired aerobic metabolism in the brain during deficiency.

Treatments


Pharmacological Treatments

  • Thiamine

    • Mechanism:
      • Replenishes deficient vitamin B1, restoring activity of thiamine-dependent enzymes critical for cerebral energy metabolism.

    • Side effects:
      • Allergic reactions

      • Injection site pain

      • Rare anaphylaxis

    • Clinical role:
      • First-line

Non-pharmacological Treatments

  • Immediate cessation of alcohol intake to prevent further thiamine depletion and neurotoxicity.

  • Nutritional support with a balanced diet rich in vitamins and minerals to aid recovery.

  • Supportive care including hydration and electrolyte correction to stabilize metabolic status.

Prevention


Pharmacological Prevention

  • Parenteral thiamine supplementation in high-risk patients such as chronic alcoholics

  • Oral thiamine prophylaxis during prolonged fasting or malnutrition

  • Intravenous thiamine administration before glucose infusion to prevent Wernicke encephalopathy

  • Multivitamin supplementation in patients with malabsorption syndromes

  • Thiamine replacement during pregnancy in hyperemesis gravidarum

Non-pharmacological Prevention

  • Avoidance of excessive alcohol consumption to reduce risk of deficiency

  • Nutritional counseling to ensure adequate dietary thiamine intake

  • Early screening for thiamine deficiency in at-risk populations

  • Management of underlying gastrointestinal disorders to improve absorption

  • Prompt treatment of vomiting and malnutrition to prevent depletion

Outcome & Complications


Complications

  • Permanent memory loss and cognitive deficits from Korsakoff syndrome

  • Wernicke encephalopathy progression to coma and death if untreated

  • Cardiomyopathy and heart failure in severe beriberi overlap

  • Peripheral neuropathy leading to chronic disability

  • Increased risk of infections due to malnutrition and immunosuppression

Short-term Sequelae Long-term Sequelae
  • Acute confusion and delirium

  • Ophthalmoplegia causing diplopia and visual disturbances

  • Gait ataxia leading to falls and injury

  • Hypotension and tachycardia from autonomic instability

  • Nausea and vomiting exacerbating nutritional deficits

  • Korsakoff syndrome with irreversible amnesia and confabulation

  • Chronic cerebellar ataxia impairing mobility

  • Persistent peripheral neuropathy with sensory and motor deficits

  • Cognitive impairment affecting executive function and learning

  • Structural brain damage visible on MRI in mammillary bodies and thalami

Differential Diagnoses


Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome) versus Alcoholic Cerebellar Degeneration

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome)

Alcoholic Cerebellar Degeneration

Acute or subacute onset of encephalopathy, ophthalmoplegia, and ataxia with potential progression to chronic memory impairment

Progressive cerebellar ataxia primarily affecting gait and stance without acute encephalopathy

Mammillary body hemorrhages or atrophy and periventricular lesions on MRI

Cerebellar vermis atrophy without mammillary body involvement

Thiamine deficiency often related to malnutrition or alcoholism

Chronic heavy alcohol use without documented nutritional deficiency

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome) versus Multiple Sclerosis

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome)

Multiple Sclerosis

Acute or subacute triad of ophthalmoplegia, ataxia, and confusion

Relapsing-remitting neurological deficits over weeks to months

Symmetric lesions in the mammillary bodies, thalamus, and periaqueductal gray

Multiple periventricular white matter plaques on MRI

Low thiamine levels and clinical response to thiamine supplementation

Oligoclonal bands in cerebrospinal fluid

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome) versus Central Pontine Myelinolysis

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome)

Central Pontine Myelinolysis

History of malnutrition or chronic alcoholism causing thiamine deficiency

Rapid correction of hyponatremia or other electrolyte disturbances

Lesions in the mammillary bodies, medial thalami, and periaqueductal gray

Central pontine demyelination on MRI

Acute onset of confusion, ophthalmoplegia, and ataxia

Rapid onset of quadriplegia and locked-in syndrome

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome) versus Hepatic Encephalopathy

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome)

Hepatic Encephalopathy

No primary liver disease but history of nutritional deficiency or alcoholism

Underlying liver failure or cirrhosis with elevated ammonia

Low thiamine levels without hyperammonemia

Elevated serum ammonia levels

Persistent encephalopathy with ocular motor abnormalities and ataxia

Fluctuating mental status with asterixis and improvement after lactulose

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome) versus Stroke (Brainstem or Thalamic Infarct)

Vitamin B1 (Thiamine) Deficiency (Wernicke-Korsakoff Syndrome)

Stroke (Brainstem or Thalamic Infarct)

Subacute onset of confusion, ophthalmoplegia, and ataxia

Sudden onset focal neurological deficits

Symmetric lesions in the mammillary bodies and periventricular regions

Focal ischemic lesion on diffusion-weighted MRI

Low serum thiamine and clinical improvement with supplementation

Vascular imaging showing arterial occlusion or stenosis

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.